within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DD07_Ceftizoxime;

model Ceftizoxime
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.6666666666666665e-06,
    adminDuration = 600,
    adminMass = 1000 / 1000000,
    adminCount = 1,
    Vd = 0.0114,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.007940000000000001,
    k12 = 4.9166666666666665e-06,
    k21 = 4.9166666666666665e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ceftizoxime</td></tr><tr><td>ATC code:</td><td>J01DD07</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>1000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>11.4</td><td>L</td></tr>
    <tr><td>clearance:</td><td>100</td><td>mL/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ceftizoxime is a third-generation cephalosporin antibiotic indicated for the treatment of a variety of bacterial infections including respiratory tract, urinary tract, skin and soft tissue infections. It was previously widely used but has been largely replaced by newer agents and is not commonly used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single intravenous injection.</p><h4>References</h4><ol><li><p>Karna, P, et al., &amp; Gooch, WM (1993). Population pharmacokinetics of ceftizoxime in premature newborns. <i>Developmental pharmacology and therapeutics</i> 20(3-4) 135–143. DOI:<a href=\"https://doi.org/10.1159/000457554\">10.1159/000457554</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7828445/\">https://pubmed.ncbi.nlm.nih.gov/7828445</a></p></li><li><p>Facca, B, et al., &amp; Triesenberg, S (1998). Population pharmacokinetics of ceftizoxime administered by continuous infusion in clinically ill adult patients. <i>Antimicrobial agents and chemotherapy</i> 42(7) 1783–1787. DOI:<a href=\"https://doi.org/10.1128/AAC.42.7.1783\">10.1128/AAC.42.7.1783</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9661021/\">https://pubmed.ncbi.nlm.nih.gov/9661021</a></p></li><li><p>Blouin, RA, et al., &amp; Stoeckel, K (1989). Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects. <i>Antimicrobial agents and chemotherapy</i> 33(3) 291–296. DOI:<a href=\"https://doi.org/10.1128/AAC.33.3.291\">10.1128/AAC.33.3.291</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2729925/\">https://pubmed.ncbi.nlm.nih.gov/2729925</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.J.J01DD07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ceftizoxime;
